Abscint

Developer of radiolabelled single domain antibodies to diagnose cancer and cardiac diseases

placeGanshoren, Brussels, Belgium calendar_todayFounded 2020 groups2 employees language abscint.com

Registered entities

Social engagement

Social engagement: 2.7K social following, 5 posts in the last 12 months — around the industry typical range.

Investor mix

2 investors on record; lead investors include Qbic Fund.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

3 Jun 2026
Event
SNMMI2026 Annual Meeting
Coming soon